Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care Facilities.
Moyet J, Helle F, Bourdenet G, Joseph C, Gubler B, Deschasse G, Defouilloy I, Slovenski T, François C, Liabeuf S, Schmit JL, Lanoix JP, Castelain S, Bloch F, Brochot E. Moyet J, et al. Among authors: helle f. J Nutr Health Aging. 2022;26(1):57-63. doi: 10.1007/s12603-021-1713-4. J Nutr Health Aging. 2022. PMID: 35067704 Free PMC article.
Genetic recombination of the hepatitis C virus: clinical implications.
Morel V, Fournier C, François C, Brochot E, Helle F, Duverlie G, Castelain S. Morel V, et al. Among authors: helle f. J Viral Hepat. 2011 Feb;18(2):77-83. doi: 10.1111/j.1365-2893.2010.01367.x. Epub 2010 Sep 6. J Viral Hepat. 2011. PMID: 21235686 Review.
A new tool to study ribavirin-induced haemolysis.
Brochot E, François C, Castelain S, Helle F, Van Nhien AN, Duchaussoy I, Capron D, Nguyen-Khac E, Duverlie G. Brochot E, et al. Among authors: helle f. Antivir Ther. 2012;17(7):1311-7. doi: 10.3851/IMP2308. Epub 2012 Sep 5. Antivir Ther. 2012. PMID: 22951364
The end-of-treatment ribavirin concentration predicts hepatitis C virus relapse.
Bodeau S, Durand-Maugard C, Lemaire-Hurtel AS, François C, Castelain S, Helle F, Andréjak M, Nguyen-Khac E, Duverlie G, Brochot E. Bodeau S, et al. Among authors: helle f. Ther Drug Monit. 2013 Dec;35(6):791-5. doi: 10.1097/FTD.0b013e3182966dee. Ther Drug Monit. 2013. PMID: 23942546
Simeprevir for the treatment of hepatitis C virus infection.
Izquierdo L, Helle F, François C, Castelain S, Duverlie G, Brochot E. Izquierdo L, et al. Among authors: helle f. Pharmgenomics Pers Med. 2014 Aug 14;7:241-9. doi: 10.2147/PGPM.S52715. eCollection 2014. Pharmgenomics Pers Med. 2014. PMID: 25206310 Free PMC article. Review.
Which therapeutic option for hepatitis C virus genotype 1?
Brochot E, Helle F, François C, Castelain S, Capron D, Nguyen-Khac E, Duverlie G. Brochot E, et al. Among authors: helle f. Scand J Gastroenterol. 2015 Apr;50(4):470-8. doi: 10.3109/00365521.2014.978364. Epub 2014 Nov 14. Scand J Gastroenterol. 2015. PMID: 25396710 Review.
82 results